UC San Francisco researchers have leveraged two new molecules, one of which is currently in clinical oncology trials, to devise a dual-drug therapy for alcohol use disorder (AUD), without the side effects or complications associated with current...Read more about Dual-drug therapy shows promise for treating alcohol use disorder
UC Berkeley business and chemistry alumni Geo Guillen, left, and Marco Lobba, middle, launched Catena Biosciences with Berkeley chemistry professor Matthew Francis. The trio credit Berkeley’s entrepreneurship ecosystem for their company’s rapid rise. (Photo courtesy of Catena...Read more about Berkeley startup aims to be a game changer in autoimmune disease therapy